ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2210

Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis

Marine Fauny1, Frank VERHOEVEN 2, Edem Allado 1, Eliane Albuisson 3, Caroline Morizot 1, Astrid Pinzano-Watrin 4, Isabelle Chary-Valckenaere 3 and Damien Loeuille 5, 1CHRU Nancy, VANDOEUVRE, France, 2CHU Besancon, BESANCON, France, 3Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, 4IMoPA. UMR 7365 CNRS, Vandoeuvre, France, 5Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ankylosing spondylitis (AS), imaging techniques and bone density, modified stoke ankylosing spondylitis spinal score (MSASSS), osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Thoracic and/or thoraco-abdomino-pelvic (TAP) Computed Tomography (CT) may be performed during the follow up of patients with ankylosing spondylitis (AS) and are able to assess vertebral fracture and recently to assess bone fragility thought the scanographic bone attenuation coefficient of the first lumbar vertebra (SBAC-L1).   

The objective is to evaluate the correlation between the risk of bone fragility measured by the SBAC-L1 and spine structural severity assessed by the S (Modified stoke ankylosing spondylitis spinal score) in patients with AS.

Methods: This monocentric retrospective study included patients with spondyloarthritis followed from 2009 to 2017 at the University hospital of Nancy. Patients should fulfill New-York or ASAS 2009 criteria with radiographic sacroiliitis and a thoracic or TAP CT scan and radiographies (spine, pelvis) performed with a delay which did not exceed 2 years. Osteoporotic risk factors, Dual Energy X-ray Absorptiometry (DXA) measurements and clinical characteristics were collected. The mSASSS was performed by two readers with adjudications in case of discordance. The definition of structural spine involvement is retained for a mSASSS ≥ 2. Vertebral fractures were studied on sagittal spine radiographies according to Genant classification. The SBAC-L1 was measured in Hounsfield Units (HU) on axial L1 section in trabecular bone on CT. Intra- and inter-reader reliabilities for mSASSS and vertebral fractures were calculated. A SBAC L1 ≤ 145 HU (fracture threshold) defines patients at risk of VF.

Results: A total of 73 AS patients were included (age median: 60 (53-68.5) years, 8 women (11%)), disease duration median: 24 years (12-34)). Sixty patients (82.2%) have a mSASSS ≥ 2, with a mean score of 20.7 (±21.2). Presence of partial ankylosis is observed in 37 patients (50.7%). Fifty-three patients (72.6%) presented at least one clinical risk factor of osteoporosis. Assessment of osteoporosis was explored by DXA of the spine in only 16 patients (21.9%) and 3 (18.8%) of them presented a T-score ≤ -2.5 SD. T-score of AS patients with mSASSS + tended to be higher in comparison to AS patients with mSASSS – (p=0.051). Thirteen VFs were detected in 9 patients (12.3%) of the total population, 8 from them have a mSASSS ≥ 2 and 5 have de SBAC-L1 ≤ 145 HU. The mean SBAC-L1 was 141.1 HU (±45) in the whole population, 138.1 HU for mSASSS + and 154.8 for mSASSS – respectively. Forty-two patients (57.5%) presented a SBAC-L1 ≤ 145 HU: 60% in mSASSS + and 46.2% in mSASSS-. Patients with bone bridge have a lower SBAC-L1 (123.96 ± 41.1 HU) than patients mSASSS + without vertebral ankylosis (160.4 ± 41.9 HU) (p=0.02). The number of AS patients under the fracture threshold was higher in mSASSS+ in comparison to mSASSS – (73% vs 41.9%, p=0.006). The reproducibilities are very good (over 0.8) for mSASSS, poor to moderate for VF (0.3 to 0.6) and good to excellent for radiographic sacroiliitis.

Conclusion: There is no relation between the risk of bone fragility measured by the SBAC-L1 and spine structural severity assessed by the mSASSS in patients with AS, however patients with bone bridge have significantly lower SBAC-L1 and more of them are under the fracture threshold compared to patients without bone.


Disclosure: M. Fauny, None; F. VERHOEVEN, None; E. Allado, None; E. Albuisson, None; C. Morizot, None; A. Pinzano-Watrin, None; I. Chary-Valckenaere, None; D. Loeuille, None.

To cite this abstract in AMA style:

Fauny M, VERHOEVEN F, Allado E, Albuisson E, Morizot C, Pinzano-Watrin A, Chary-Valckenaere I, Loeuille D. Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/relationship-between-structural-spine-involvement-and-the-scanographic-bone-attenuation-coefficient-of-l1-in-a-population-of-73-patients-with-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-structural-spine-involvement-and-the-scanographic-bone-attenuation-coefficient-of-l1-in-a-population-of-73-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology